Literature DB >> 31073549

New Medicare Coverage Policy for Next-Generation Tumor Sequencing: A Key Shift in Coverage Criteria With Broad Implications Beyond Medicare.

K A Phillips1,2,3,4, J R Trosman1,2,5, C B Weldon2,5, M P Douglas1,2.   

Abstract

Entities:  

Year:  2018        PMID： 31073549      PMCID： PMC6503521          DOI： 10.1200/PO.18.00206

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  10 in total

1.  Private payers disagree with Medicare over medical device coverage about half the time.

Authors:  James D Chambers; Matthew Chenoweth; Teja Thorat; Peter J Neumann
Journal:  Health Aff (Millwood)       Date:  2015-08       Impact factor: 6.301

2.  Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?

Authors:  Kathryn A Phillips; Patricia A Deverka; Gillian W Hooker; Michael P Douglas
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

3.  A new model for reimbursing genome-based cancer care.

Authors:  Scott D Ramsey; Sean D Sullivan
Journal:  Oncologist       Date:  2013-12-05

4.  Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.

Authors:  Julia R Trosman; Christine B Weldon; Michael P Douglas; Allison W Kurian; R Kate Kelley; Patricia A Deverka; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2017-02-10       Impact factor: 11.908

5.  Payer coverage policies for multigene tests.

Authors:  Kathryn A Phillips; Patricia A Deverka; Julia R Trosman; Michael P Douglas; James D Chambers; Christine B Weldon; Andrew P Dervan
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

6.  Insurance for broad genomic tests in oncology.

Authors:  Rebecca Eisenberg; Harold Varmus
Journal:  Science       Date:  2017-12-01       Impact factor: 47.728

7.  Insurance coverage for genomic tests.

Authors:  Kathryn A Phillips; Julia R Trosman; Patricia A Deverka; Bruce Quinn; Sean Tunis; Peter J Neumann; James D Chambers; Louis P Garrison; Michael P Douglas; Christine B Weldon
Journal:  Science       Date:  2018-04-19       Impact factor: 47.728

8.  Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

Authors:  Julia R Trosman; Christine B Weldon; R Kate Kelley; Kathryn A Phillips
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

9.  From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Authors:  Julia R Trosman; Christine B Weldon; William J Gradishar; Al B Benson; Massimo Cristofanilli; Allison W Kurian; James M Ford; Alan Balch; John Watkins; Kathryn A Phillips
Journal:  Value Health       Date:  2018-08-03       Impact factor: 5.725

10.  Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

Authors:  Kathryn A Phillips
Journal:  JAMA       Date:  2018-06-19       Impact factor: 56.272
  10 in total
  2 in total

1.  Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.

Authors:  Julia R Trosman; Michael P Douglas; Su-Ying Liang; Christine B Weldon; Allison W Kurian; Robin K Kelley; Kathryn A Phillips
Journal:  Value Health       Date:  2020-03-19       Impact factor: 5.725

2.  Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.

Authors:  Daniel M Sheinson; William B Wong; Carlos Flores; Sarika Ogale; Cary P Gross
Journal:  JCO Oncol Pract       Date:  2021-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.